Engage with the largest network of potential partners to accelerate your cross-border strategies and expand your reach into the China market.
ChinaBio® Partnering Forum is the largest and most productive life science partnering event in China. To be held as a 4-day hybrid event; 2 days in-person, 2 days virtually, September 20-21, 2023, the conference will bring together biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for four days of successful partnering.
ChinaBio® Partnering Forum 2022 attracted 1,000+ delegates from over 500 companies and 27 countries, making it a must-attend global event for companies interested in developing cross-border partnerships, both inside and outside of China. The 2023 edition promises to be even better with the added ability to attend in-person and virtually, with top notch attendance from pharma and biotech companies and investors, as well as leading executives from China's fast-growing life sciences hubs and researchers from China's top universities and institutes.
The conference also features EBD Group's gold-standard partnering platform, partneringONE®, enabling delegates to efficiently identify, meet and network with companies from across the life science value chain in a virtual format, with each meeting prescheduled with its own video conferencing link.
In addition to partnering meetings, the event will feature a blend of live and on-demand program sessions, company presentations, table-top exhibits, company showcases, and networking sessions.
ChinaBio® Partnering Forum is the largest and most productive life science partnering event in China. To be held as a 4-day hybrid event; 2 days in-person, 2 days virtually, September 20-21, 2023, the conference will bring together biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for four days of successful partnering.
ChinaBio® Partnering Forum 2022 attracted 1,000+ delegates from over 500 companies and 27 countries, making it a must-attend global event for companies interested in developing cross-border partnerships, both inside and outside of China. The 2023 edition promises to be even better with the added ability to attend in-person and virtually, with top notch attendance from pharma and biotech companies and investors, as well as leading executives from China's fast-growing life sciences hubs and researchers from China's top universities and institutes.
The conference also features EBD Group's gold-standard partnering platform, partneringONE®, enabling delegates to efficiently identify, meet and network with companies from across the life science value chain in a virtual format, with each meeting prescheduled with its own video conferencing link.
In addition to partnering meetings, the event will feature a blend of live and on-demand program sessions, company presentations, table-top exhibits, company showcases, and networking sessions.
